December 5, 2021

Covishield vaccine: kab lagegi corona ki vaccine


Highlights:

  • Serum Institute Prepares 4-5 Crore Doses of Covishield Vaccine
  • Vaccine production will depend on the government’s total demand
  • By next month, this vaccine can also be approved in India

new Delhi
The Serum Institute of India (SII) has so far produced around 4-5 crore doses of the Oxford AstraZeneca Kovid-19 vaccine ‘Kovishield’. The company said on Monday that it aims to produce 100 million doses by March next year. The company’s CEO Adar Poonawala said on Monday that we are waiting for the approval of the right to emergency use of this vaccine.

Vaccine production will depend on the government’s total demand
The company said that the production of Kovid-19 vaccine would depend on the total demand from the government. SII partnered with Oxford University and Estrogenka to manufacture Covishield in view of the urgent need to introduce Kovid-19 vaccine in India. The Pune-based company has applied to the Drug Controller General of India (DGCI) for emergency use of the Kovid-19 vaccine.

vaccine update in india: Good news before Corona vaccine, pneumonia’s first ‘Made in India’ vaccine launched
Initially the pace of introduction of vaccine will be slow
Poonawala said, ‘We have already manufactured 4-5 crore doses of the vaccine. Initially the pace of introduction of the vaccine will be slow due to logistics issues. However, once things are in place we will be able to take out the vaccine fast. He said that the company plans to increase the vaccine’s monthly production to 100 million doses by March next year.

Covaxin in Varanasi: vaccine to arrive in second week of January, 12,700 vaccine to be vaccinated in first phase
Approval can be received in India next month
Adar Poonawala said that the Oxford / AstraZeneca vaccine would be approved in Britain soon. The vaccine is also expected to be approved in India by next month. He said that most of the production will go to India. However, some vaccines will also be given to other countries under the global initiative Kovacs. He said that there might be some shortage of vaccines during the first 6 months, but things would be fine by August-September after starting supply from other manufacturers.

Corona vaccine’s unique reception in Germany, the pilot made a model of syringes in the air
Dry run for vaccine in 4 states on Monday
Dry run was conducted in 4 states (Assam, Andhra Pradesh, Punjab and Gujarat) on 28 December i.e. Monday in view of preparations for corona vaccination. On Monday, 125-125 people from four states who registered for vaccination through the Co-Win app were sent an SMS and were informed of the time and place for the rehearsal of the Kovid-19 vaccination.

Covishield


navbharattimes.indiatimes.com

Leave a Reply

Your email address will not be published. Required fields are marked *